Faron Pharmaceuticals Oy
FPHAF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $282,090 | $234,783 | $205,757 | $215,689 |
| - Cash | $9,503 | $6,875 | $6,990 | $6,853 |
| + Debt | $12,113 | $13,111 | $13,269 | $3,547 |
| Enterprise Value | $284,700 | $241,019 | $212,036 | $212,383 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$18 | -$28,371 | -$27,057 | -$20,802 |
| % Margin | – | – | – | – |
| Net Income | -$26 | -$30,944 | -$30,034 | -$21,194 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0.341 | -0.381 | -0.291 |
| % Growth | 99.9% | 10.4% | -31% | – |
| Operating Cash Flow | -$22,971 | -$23,806 | -$22,993 | -$22,218 |
| Capital Expenditures | -$226 | -$123 | -$385 | -$474 |
| Free Cash Flow | -$23,197 | -$23,929 | -$23,378 | -$22,692 |